Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Index by author

December 01, 2001; Volume 68,Issue 12
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Chew, Derek P.

    1. You have access
      GP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell us
      Derek P. Chew, MBBS and David J. Moliterno, MD
      Cleveland Clinic Journal of Medicine December 2001, 68 (12) 1017-1023;

      Recent trials addressed whether there are clinical differences among these drugs, whether their empiric use is justified in acute coronary syndromes, and whether they might allow for early invasive management in acute coronary syndromes.

  2. Clough, John D.

    1. You have access
      Bioterrorism: An unintended boost to public health?
      John D. Clough, MD
      Cleveland Clinic Journal of Medicine December 2001, 68 (12) 971;

      If anything good comes of recent events, it might be rejuvination of America’s public health system, which has languished in recent years.

Back to top
PreviousNext

In this issue

Cleveland Clinic Journal of Medicine: 68 (12)
Cleveland Clinic Journal of Medicine
Vol. 68, Issue 12
1 Dec 2001
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Sign up for alerts
  • Editor's Picks
  • Most Cited
  • Most Read
Loading
  • Meta-analysis: Its strengths and limitations
  • Primary angiitis of the central nervous system: diagnostic criteria and clinical approach
  • The essential role of exercise in the management of type 2 diabetes
  • Role of uric acid in hypertension, renal disease, and metabolic syndrome
  • Frailty in older adults: Implications for end-of-life care
More...

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire